Skip to main content

SRX Global Inc.

corporate_fare Company Profile

SRX Global Inc.

SRXH·NYSE·Manufacturing·CIK 0001471727

SRX Global Inc. operates a pet health and wellness business, the continuing operations formerly operated by Better Choice Company, Inc. following a reverse merger. The business focuses on providing high-quality pet products under the Halo brand, including foods, treats, toppers, dental products, chews, and supplements for dogs and cats. Products are sold across multiple channels: e-commerce platforms such as Amazon and Chewy, select retail partners, and international distributors. The direct-to-consumer channel through halopets.com was exited in June 2024, and consumers are now directed to retail partners for online purchase. The company continues to operate this business post-RTO, including managing product innovation, brand positioning, and supply chain relationships with co-manufacturers. The Halo portfolio includes Halo Holistic™ and Halo Elevate®, designed for pet parents seeking high-quality, science-based nutrition for their pets. Continuing operations include over 100 premium and super-premium pet health and wellness products across multiple forms, including kibble, canned food, freeze-dried raw food, treats, and supplements. All products are formulated to meet high-quality sourcing and nutritional standards, leveraging longstanding co-manufacturing relationships. The company's legacy specialty pharmaceuticals and healthcare services operations, historically conducted under SRx, are classified as discontinued operations following bankruptcy and the subsequent winding down of these activities. Historically, SRx provided specialty pharmaceutical products and related services to healthcare providers and patients across various therapeutic areas, and pursued acquisitions and expansion strategies aimed at growing its product portfolio and market presence. Due to financial challenges, SRx filed for bankruptcy, resulting in the termination, sale, or wind-down of its operations.

SRX Global Inc. (NYSE:SRXH) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 1 item for SRXH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Recent SEC coverage for SRXH spans SCHEDULE 13D.

Recent high-impact activity:

  • Two Investors Form 9.9% Group in SRX Global, Target Board Changes

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$6.53M
Net Income
-$45.01M
Diluted EPS
-$2.13
Op. Cash Flow
-$8.14M
Gross Profit
$1.53M
Operating Income
-$11.41M
Cash & Equivalents
$1.31M
Total Debt
$4.45M
Debt / Equity
10.94×
Net Margin
-6.89×
Shares Outstanding
24.92M sh
Source: 10-K · filed 2025-12-05 · accession 0001493152-25-026452

Short Interest & Short Volume

2.30 days to cover

FINRA reported short interest of 998,470 shares in SRXH as of the October 30, 2026 settlement, a 47.6% decrease from the prior period — about 2.3 days to cover at its recent average daily volume. On November 20, 2026, 83.2% of SRXH volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)998,470 shares as of October 30, 2026
Change vs prior period▼ 47.6%
Days to cover2.30 at avg daily volume of 434,291
Daily short volume (FINRA facilities)83.2% of 616,804 shares on November 20, 2026
5-day average short volume73.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.8015 +0.19% today
52-week range · as of 2026-11-20 $0.7102 – $42.61
Market cap
$16.15M
Volume
1.1M (2.4× avg)
3-mo avg 465.3K
Live data · 2026-11-21 07:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SRXH - Latest Insights

SRXH
Nov 20, 2026, 8:45 AM EST
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.8015 info
Change: -$0.2085 (-21%) info
Market Cap: $16.148M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets